Escalon Medical (OTCMKTS:ESMC – Get Free Report) released its quarterly earnings data on Monday. The medical equipment provider reported $0.02 EPS for the quarter, Zacks reports. The business had revenue of $3.71 million for the quarter. Escalon Medical had a return on equity of 65.44% and a net margin of 31.50%.
Escalon Medical Stock Performance
ESMC stock remained flat at $0.19 during midday trading on Wednesday. 45,000 shares of the company’s stock were exchanged, compared to its average volume of 3,059. The company’s fifty day moving average price is $0.17 and its 200-day moving average price is $0.19. Escalon Medical has a 12 month low of $0.14 and a 12 month high of $0.28. The company has a current ratio of 2.94, a quick ratio of 2.21 and a debt-to-equity ratio of 0.03. The company has a market capitalization of $1.40 million, a P/E ratio of 0.73 and a beta of 0.65.
About Escalon Medical
Escalon Medical Corporation develops, manufactures and markets medical devices for ophthalmology. Its products support eye-care professionals in diagnosing and treating eye conditions, with a focus on diagnostic imaging and surgical applications. The company’s offerings include ophthalmic ultrasound systems and related diagnostic instruments, as well as products used in eye surgery. Its Sonomed line is associated with ophthalmic ultrasound technology. Escalon has served eye-care markets in the United States and internationally.
See Also
- Five stocks we like better than Escalon Medical
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
- SpaceX’s Wild Ride Puts 2 Space Stocks and a Weekly-Payout ETF in Focus
- Palantir’s Political Controversy Is Hiding a Much Bigger Story
- General Motors Faces a Cost Squeeze as Factory Automation Takes Center Stage
Receive News & Ratings for Escalon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Escalon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
